A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
E2007-A001-206
Study Overview
E2007
perampanel
NCT00144690, EU CTR 2005-004199-18
Mar 2005 - Feb 2007
Epilepsy
Determination of the maximum tolerated dose (MTD)
Males and females (age 18 to 70 years)
Completed
Phase
2
Australia, Czech Republic, Germany, Lithuania, Sweden, United Kingdom, United States See moreSee less
Results
CSR Synopsis
No download available
Lay Summary
No download available
Publication reference citation
Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, et al. Tolerability and safety of perampanel: Two randomized dose-escalation studies. Acta Neurol Scand 2012 01;125(1):8-15. DOI: 10.1111/j.1600-0404.2011.01588.x
Data Sharing
ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.
Redacted documents are available upon request for this study.